| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 2.212.163 | 5.795.577 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 2.212.731 | 5.795.603 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 2.425.792 | 6.148.207 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | -213.061 | -352.603 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | -252.225 | -488.766 |
| Employees | - | - | - | - | - | - | - | - | 56 | 54 |
Check the financial reports for the company - Biocodex S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 214.202 | 251.514 |
| Current Assets | - | - | - | - | - | - | - | - | 2.475.430 | 2.116.085 |
| Inventories | - | - | - | - | - | - | - | - | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | - | 2.264.476 | 1.099.816 |
| Cash | - | - | - | - | - | - | - | - | 210.954 | 1.016.268 |
| Shareholders Funds | - | - | - | - | - | - | - | - | -153.367 | -641.276 |
| Social Capital | - | - | - | - | - | - | - | - | 98.858 | 98.305 |
| Debts | - | - | - | - | - | - | - | - | 2.773.945 | 2.719.464 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Biocodex S.r.l.